Skip to main content

Gen-Probe Licenses Molecular Dx Technology from Xceed

NEW YORK (GenomeWeb News) – Xceed Molecular announced yesterday that Gen-Probe has taken a non-exclusive license to the firm’s Flow-Thru Chip technology.
The Wellesley, Mass.-based company said that Gen-Probe expects to use the technology in developing next-generation multiplexed molecular diagnostics.
Under terms of the deal, Gen-Probe will pay up-front licensing and milestone fees to Xceed for non-exclusive access to the chip technology in certain fields. Gen-Probe also has the right to receive co-exclusive rights with Xceed in certain undisclosed sub-fields. San Diego-based Gen-Probe also will make royalty payments to Xceed based on sales and will purchase Xceed’s custom TipChips, Ziplex automated gene expression system, and other Xceed products.
“There are many promising applications for moderate-density arrays in clinical diagnostics and other applications, and we believe that Xceed’s technologies in combination with our own technologies will facilitate our entry into these expanding markets,” Dan kacian, executive vice president and chief scientist for Gen-Probe, said in a statement.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.